Mónica Marazuela Azpiroz-rekin lankidetzan egindako argitalpenak (7)

2022

  1. Impact of Change in Body Composition during Follow-Up on the Survival of GEP-NET

    Cancers, Vol. 14, Núm. 21

2020

  1. Lat-1 and glut-1 carrier expression and its prognostic value in gastroenteropancreatic neuroendocrine tumors

    Cancers, Vol. 12, Núm. 10, pp. 1-18

2018

  1. Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors

    Oncotarget, Vol. 7, Núm. 6, pp. 6593-6608

2013

  1. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. the large experience of the spanish national tumor registry (RGETNE)

    Neuroendocrinology, Vol. 98, Núm. 2, pp. 156-168

2010

  1. The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors

    Endocrine-Related Cancer, Vol. 17, Núm. 4, pp. 897-908

2005

  1. Diagnosis and treatment of insulinoma: Review of 10 patients

    Endocrinologia y Nutricion, Vol. 52, Núm. 7, pp. 338-343